| 000 | 01491 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514053502.0 | ||
| 264 | 0 | _c20030430 | |
| 008 | 200304s 0 0 eng d | ||
| 022 | _a0300-5038 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHercberg, S | |
| 245 | 0 | 0 |
_aThe SU.VI.MAX trial on antioxidants. _h[electronic resource] |
| 260 |
_bIARC scientific publications _c2002 |
||
| 300 |
_a451-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMinerals _xadministration & dosage |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xepidemiology |
| 650 | 0 | 4 |
_aNeoplasms _xepidemiology |
| 650 | 0 | 4 | _aNutritional Status |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVitamins _xadministration & dosage |
| 700 | 1 | _aGalan, P | |
| 700 | 1 | _aPreziosi, P | |
| 700 | 1 | _aMalvy, M | |
| 700 | 1 | _aBriançon, S | |
| 700 | 1 | _aAit, Hadad M | |
| 700 | 1 | _aRahim, B | |
| 700 | 1 | _aFavier, A | |
| 773 | 0 |
_tIARC scientific publications _gvol. 156 _gp. 451-5 |
|
| 999 |
_c12288676 _d12288676 |
||